New hope for PTSD: drug trial targets Veterans' trauma symptoms
NCT ID NCT05948579
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This study tests whether the drug vilazodone can reduce PTSD symptoms in 200 active-duty service members and veterans. Participants will receive either the drug or a placebo, and researchers will track changes in symptom severity and safety over 12 weeks. The goal is to find a better treatment option for those affected by trauma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.